Cargando…
Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells
Chemotherapy is a common treatment for leukemia. Ruthenium complexes have shown potential utility in chemotherapy and photodynamic therapy. The identification of new chemotherapeutics agents is critical for further progress in the treatment of leukemia. Ruthenium complexes generally have lower toxic...
Autores principales: | Pereira, Flávia de Castro, de Lima, Aliny Pereira, Vilanova-Costa, Cesar Augusto Sam Tiago, Pires, Wanessa Carvalho, Ribeiro, Alessandra de Santana Braga Barbosa, Pereira, Lucas Carlos Gomes, Pavanin, Luiz Alfredo, dos Santos, Wagner Batista, Silveira-Lacerda, Elisângela de Paula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082535/ https://www.ncbi.nlm.nih.gov/pubmed/25019046 http://dx.doi.org/10.1186/2193-1801-3-301 |
Ejemplares similares
-
Cytoxicity and Apoptotic Mechanism of Ruthenium(II) Amino Acid Complexes in Sarcoma-180 Tumor Cells
por: Lima, Aliny Pereira, et al.
Publicado: (2014) -
Tetraammine(carbonato-κ(2)
O,O′)cobalt(III) perchlorate
por: Mohan, Singaravelu Chandra, et al.
Publicado: (2013) -
Influence of Different Zeolite Frameworks on the Geometry
of Platinum(II)tetraammine
Complex
por: Selvaraj, Tamilmani, et al.
Publicado: (2018) -
1,2-Dimorpholinoethane-1,2-dithione
por: Yu, Yan-Ping, et al.
Publicado: (2009) -
Calcitonin receptor gene expression in K562 chronic myelogenous leukemic cells
por: Mould, Richard, et al.
Publicado: (2003)